Nyxoah (NYXH) Income from Continuing Operations (2021 - 2026)
Nyxoah (NYXH) recorded quarterly Income from Continuing Operations of 18209777.84 in Q1 2026, down 99.93% quarter-over-quarter from 26328336215.46 in Q4 2025, and down 22.23% on a YoY basis from 23413895.74 in Q1 2025.
Nyxoah (NYXH) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Nyxoah's Income from Continuing Operations history runs 6 years deep, the most recent figure standing at 18209777.84 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 22.23% year-over-year to 18209777.84; the TTM figure through Mar 2026 stood at 26295629039.77 (up 263.59% YoY), while the FY2025 annual figure was 104862860.02, down 65.66% from the prior year.
- Income from Continuing Operations was 18209777.84 for Q1 2026 at Nyxoah, down from 26328336215.46 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 26328336215.46 in Q4 2025 to a low of 16102664085.05 in Q4 2024.
- Historically, Income from Continuing Operations has averaged 99687652.97 across 5 years, with a median of 6226093.99 in 2022.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations slumped 172854.78% in 2023, then jumped 273.1% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 12759213550.4 in 2022, then sank by 194.61% to 12070969838.86 in 2023, then slumped by 33.4% to 16102664085.05 in 2024, then jumped by 263.5% to 26328336215.46 in 2025, then tumbled by 99.93% to 18209777.84 in 2026.
- The last three Income from Continuing Operations figures came in at 18209777.84 (Q1 2026), 26328336215.46 (Q4 2025), and 27905345.03 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | 18.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.21 Mn |
| Dec 31, 2025 | 26.33 Bn |
| Sep 30, 2025 | -27.91 Mn |
| Jun 30, 2025 | -23.01 Mn |
| Mar 31, 2025 | 23.41 Mn |
| Dec 31, 2024 | -16.10 Bn |
| Sep 30, 2024 | 18.54 Mn |
| Jun 30, 2024 | -13.66 Mn |
| Mar 31, 2024 | 12.81 Mn |
| Dec 31, 2023 | -12.07 Bn |
| Sep 30, 2023 | -10.71 Mn |
| Jun 30, 2023 | -12.92 Mn |
| Mar 31, 2023 | -12.59 Bn |
| Dec 31, 2022 | 12.76 Bn |
| Sep 30, 2022 | -6.23 Mn |
| Jun 30, 2022 | -5.21 Mn |
| Mar 31, 2022 | 7.29 Mn |
| Dec 31, 2021 | 4.04 Bn |
| Sep 30, 2021 | -10.17 Mn |
| Jun 30, 2021 | 8.24 Mn |